Andy Hill (NuVision Biotherapies) discusses recent AOP update to clinical guidelines
8 December 2023
|
NuVision, Andy Hill, amniotic membranes, guidelines, AOP, optometrist, outpatient, dry eye, lens
There are currently 600,000 people on the NHS waiting list for ophthalmology treatment, and over 5 million people in the UK currently live with dry eye disease. Here Andy Hill, CEO at NuVision Biotherapies Ltd, discusses a recent update to clinical guidelines and what this means for optometrists, patients, and taxpayers.
